Recombinant VEGF (Bevacizumab Biosimilar) anticorps
Reactivité: Humain
FACS, ELISA, WB, BR, IP
Hôte: Souris
Chimeric
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits VEGF (Bevacizumab Biosimilar)
- VEGF (Bevacizumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Chimeric
-
Conjugué
- Cet anticorp VEGF (Bevacizumab Biosimilar) est non-conjugé
-
Application
- Flow Cytometry (FACS), ELISA, Western Blotting (WB), Blocking Reagent (BR), Immunoprecipitation (IP)
- Attributs du produit
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Purification
- Purified antibody.
- Immunogène
- Recombinant human VEGF.
- Isotype
- IgG2a kappa
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Antigène
- VEGF (Bevacizumab Biosimilar)
- Abstract
- VEGF (Bevacizumab Biosimilar) Produits
- Synonymes
- anticorps MVCD1, anticorps VEGF, anticorps VPF, anticorps vascular endothelial growth factor A, anticorps VEGFA
- Sujet
- Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF
- UniProt
- P15692
-
Vous êtes ici:
